Veterinary Anti-infectives Market: By Drug Type (Anti-viral Drugs, Anti-bacterial Drugs, Parasiticides, Anti-fungal Drugs, Others), By Disease Type (Dermatological infections, Respiratory infections, Gastrointestinal Infections, Ophthalmic Infections, Others), By Species Type (Farm Animals (Cattle, Aqua, Swine, Sheep, Poultry, Others), Companion Animals (Canines, Felines, Horses, Rabbits, Others)), By Route Of Administration (Oral, Parenteral, Topical, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies, Others) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Veterinary Anti-infectives Market Size was valued at USD 1.42 billion in 2023 and is poised to grow at a CAGR of 3.6% from 2024-2030. Veterinary anti-infectives are medications that work to prevent or treat infections in animals by inhibiting the spread of an infectious organism or by killing the infectious organism outright. Animals might acquire a number of infections that are transmitted by food, water, or even zoonotic diseases. According to the global animal health association, it’s estimated that one in five farm animals are lost due to diseases each year with 20% of animals lost to preventable diseases. The zoonotic diseases i.e., diseases spread from animals to humans like Rabies, Anthrax, Brucellosis, Foot and Mouth disease, and others. The veterinary anti-infectives market driving factors include increased awareness among the farmers coupled with the availability of novel therapeutics, favourable government policies. For example, in 2014, West Africa experienced the largest Ebola outbreak infecting 28,616 people and 11,310 deaths. Moreover, the pressure to maintain veterinary health standards of dairy products, fresh meat, and dietary nutrition creates pressure on livestock owners which is expected to hasten the use of veterinary anti-infectives. Furthermore, the increased adoption of pets has increased the veterinary anti-infectives market.

According to the American Society for the Prevention of Cruelty to Animals (ASPCA) more than 23 million American households adopted a pet in the pandemic duration. Improvisation in research and development, and product innovation in areas such as biologics and specialty care provide a huge array of opportunities for this market. Additionally, the veterinary anti-infectives market is expected to experience considerable development prospects, particularly for new market entrants, due to the rising affordability of therapies and rising consumer awareness of livestock and pet care. Based on drug type, the anti-bacterial segment has accounted for major revenue share. For instance, according to research conducted in Tanzania, Tanzania Medicines and Medical Devices Authority (TMDA) recorded, a total of 12,147,491 kg of antibiotics consumption from 2010 to 2017. But the presence of substandard or counterfeit drugs hinders the growth of the market. Moreover, the increased cost of veterinary services and lack of accessibility to vets along with the negligence of livestock owners with numerous animals towards the sick cattle is decreasing the value of the veterinary anti-infectives market. However, increased investments by major industry leaders in research and development, entry of generic medicines, developed infrastructure, increased demand for poultry food items, and increased rate of pet adoption are major facets in this market contributing towards its overall growth and are expected to increase the market in the forecast years.

Veterinary Anti-infectives Market Key Developments:
  • In September 2022, Zoetis acquired Jurox, a leading animal health company that develops, manufactures, and markets a wide range of veterinary medicines for treating livestock and companion animals.
  • In July 2022, Dechra Pharmaceuticals of Northwich, England acquired Greensboro-based Piedmont Animal Health, an innovator of more than 30 pet medicines sold by major global brands for $210 million.

Global Veterinary Anti Infectives Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Veterinary Anti Infectives Market Dynamics

Increase in the global animal adoption rate, a rise in the prevalence of foodborne and zoonotic diseases, increase in the R&D activities for innovation of new products, and government initiations for the animal healthcare are anticipated to fuel the veterinary anti-infectives market. Moreover, increase in the preference for healthy meat and other dairy products, a rise in awareness about the animal infectious diseases, lack of awareness about veterinary vaccines, and growing animal healthcare expenditure expected to boost the veterinary anti-infectives market over the forecast period. However, stringent regulatory policies for veterinary medicines and lack of awareness about the anti-infective drugs in underdeveloped regions might hinder the growth of veterinary anti-infectives market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Veterinary Anti Infectives Market Segmentation

By Drug-Distribution
  • Anti-viral Drugs
  • Anti-bacterial Drugs
  • Parasiticides
  • Anti-fungal Drugs
  • Others
By Disease Type
  • Dermatological infections
  • Respiratory infections
  • Gastrointestinal infections
  • Ophthalmic infections
  • Others
By Species Type
  • Farm Animals
  • Companion Animals
By Route-Administration
  • Oral
  • Parenteral
  • Topical
  • Others
By Distribution Channel
  • Veterinary Hospitals,
  • Veterinary Pharmacies,
  • Online Pharmacies,
  • Others

Frequently Asked Questions

The veterinary anti-infectives market Size was valued at USD 1.4 billion in 2023

Zoetis, Inc. (Pfizer) (U.S) Virbac AH Inc. (France) Sanofi S.A. (France) Boehringer Ingelheim Vetmedica, Inc. (Boehringer Ingelheim) (Germany) Bayer HealthCare LLC, (Bayer AG) (Germany) Merck Animal Health (Merck &co. Inc.) (U.S.) Dechra Pharmaceuticals (U.K.) NovaBay Pharmaceuticals, Inc. (U.S.)

The Increasing Zoonotic and Foodborne Diseases

1.Executive Summary
2.Global Veterinary Anti Infectives Market Introduction 
2.1.Global Veterinary Anti Infectives Market  - Taxonomy
2.2.Global Veterinary Anti Infectives Market  - Definitions
2.2.1.Drug-Distribution
2.2.2.Disease Type
2.2.3.Species Type
2.2.4.Route-Administration
2.2.5.Distribution Channel
2.2.6.Region
3.Global Veterinary Anti Infectives Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Veterinary Anti Infectives Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Veterinary Anti Infectives Market  By Drug-Distribution, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Anti-viral Drugs
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Anti-bacterial Drugs
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Parasiticides
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Anti-fungal Drugs
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Veterinary Anti Infectives Market  By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Dermatological infections
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Respiratory infections
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Gastrointestinal infections
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Ophthalmic infections
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Veterinary Anti Infectives Market  By Species Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Farm Animals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Companion Animals
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Veterinary Anti Infectives Market  By Route-Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Oral
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Parenteral
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Topical
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Veterinary Anti Infectives Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Veterinary Anti Infectives Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Drug-Distribution Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Anti-viral Drugs
10.1.2.Anti-bacterial Drugs
10.1.3.Parasiticides
10.1.4.Anti-fungal Drugs
10.1.5.Others
10.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Dermatological infections
10.2.2.Respiratory infections
10.2.3.Gastrointestinal infections
10.2.4.Ophthalmic infections
10.2.5.Others
10.3.  Species Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Farm Animals
10.3.2.Companion Animals
10.4.  Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Oral
10.4.2.Parenteral
10.4.3.Topical
10.4.4.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Veterinary Anti Infectives Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Drug-Distribution Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Anti-viral Drugs
11.1.2.Anti-bacterial Drugs
11.1.3.Parasiticides
11.1.4.Anti-fungal Drugs
11.1.5.Others
11.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Dermatological infections
11.2.2.Respiratory infections
11.2.3.Gastrointestinal infections
11.2.4.Ophthalmic infections
11.2.5.Others
11.3.  Species Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Farm Animals
11.3.2.Companion Animals
11.4.  Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Oral
11.4.2.Parenteral
11.4.3.Topical
11.4.4.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Veterinary Anti Infectives Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Drug-Distribution Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Anti-viral Drugs
12.1.2.Anti-bacterial Drugs
12.1.3.Parasiticides
12.1.4.Anti-fungal Drugs
12.1.5.Others
12.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Dermatological infections
12.2.2.Respiratory infections
12.2.3.Gastrointestinal infections
12.2.4.Ophthalmic infections
12.2.5.Others
12.3.  Species Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Farm Animals
12.3.2.Companion Animals
12.4.  Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Oral
12.4.2.Parenteral
12.4.3.Topical
12.4.4.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Veterinary Anti Infectives Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Drug-Distribution Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Anti-viral Drugs
13.1.2.Anti-bacterial Drugs
13.1.3.Parasiticides
13.1.4.Anti-fungal Drugs
13.1.5.Others
13.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Dermatological infections
13.2.2.Respiratory infections
13.2.3.Gastrointestinal infections
13.2.4.Ophthalmic infections
13.2.5.Others
13.3.  Species Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Farm Animals
13.3.2.Companion Animals
13.4.  Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Oral
13.4.2.Parenteral
13.4.3.Topical
13.4.4.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Veterinary Anti Infectives Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Drug-Distribution Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Anti-viral Drugs
14.1.2.Anti-bacterial Drugs
14.1.3.Parasiticides
14.1.4.Anti-fungal Drugs
14.1.5.Others
14.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Dermatological infections
14.2.2.Respiratory infections
14.2.3.Gastrointestinal infections
14.2.4.Ophthalmic infections
14.2.5.Others
14.3.  Species Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Farm Animals
14.3.2.Companion Animals
14.4.  Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Oral
14.4.2.Parenteral
14.4.3.Topical
14.4.4.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Zoetis, Inc. (Pfizer) (U.S)
15.2.2.Virbac AH Inc. (France)
15.2.3.Sanofi S.A. (France)
15.2.4.Boehringer Ingelheim Vetmedica, Inc. (Boehringer Ingelheim) (Germany)
15.2.5.Bayer HealthCare LLC, (Bayer AG) (Germany)
15.2.6.Merck Animal Health (Merck &co. Inc.) (U.S.)
15.2.7.Dechra Pharmaceuticals (U.K.)
15.2.8.NovaBay Pharmaceuticals, Inc. (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Zoetis, Inc. (Pfizer) (U.S)
  • Virbac AH Inc. (France)
  • Sanofi S.A. (France)
  • Boehringer Ingelheim Vetmedica, Inc. (Boehringer Ingelheim) (Germany)
  • Bayer HealthCare LLC, (Bayer AG) (Germany)
  • Merck Animal Health (Merck &co. Inc.) (U.S.)
  • Dechra Pharmaceuticals (U.K.)
  • NovaBay Pharmaceuticals, Inc. (U.S.)

Adjacent Markets